PEDIATRICS Vol. 102 No. 2 August 1998, pp. 355-359
Received Dec 10, 1997; accepted Mar 3, 1998.
,
,
,
From the * Division of Cancer Epidemiology and Genetics, Viral
Epidemiology Branch, National Cancer Institute, National Institutes of
Health, Bethesda, Maryland; the
Departments of Obstetrics and
Gynecology and Medicine, State University of New York Health Science
Center at Brooklyn, Brooklyn, New York; the § Science Application
International Corporation, Frederick Cancer Research Center, Frederick,
Maryland; the
Department of Hygiene and Epidemiology, Athens
University and Medical School, Athens, Greece; the ¶ Department of
Pediatrics, Walter Reed Army Medical Center, Washington, District of
Columbia; the # Department of Pediatrics, Albert Einstein College of
Medicine, Bronx, New York; and the ** Department of Medicine, St Louis
University School of Medicine, St Louis, Missouri.
Objectives. To estimate the hepatitis C virus (HCV) vertical transmission rate, the effect of potential risk factors, and the pattern of HCV antibody response and viremia in HCV-infected infants.
Study Design. The Mothers and Infants Cohort Study enrolled both human immunodeficiency virus (HIV)-seropositive and HIV-seronegative pregnant women at five obstetric clinics in New York City in a prospective cohort study between January 1986 and January 1991. HCV-infected mothers and their 122 offspring were followed-up for a minimum of 12 months for evidence of HCV infection as determined by persistent HCV antibodies or detection of HCV RNA by reverse transcription polymerase chain reaction. Comparisons among groups for categorical variables were performed using the Fisher's exact test.
Results. Seven (6%; 95% confidence interval, 2%-11%) of the 122 infants were HCV-infected. There was a tendency for increased risk of transmission with maternal viral and obstetrical factors, such as coinfection with HIV (7% vs 4%), high HIV viral load (13% vs 6%), HCV viremia (8% vs 3%), vaginal delivery (6% vs 0%), and female gender of offspring (8% vs 3%), although none of the associations reached statistical significance. After loss of maternal antibody, HCV antibody seroconversion occurred at a mean age of 26 months in 3 HIV-coinfected infants compared with 7 months of age in 4 HCV-infected HIV-uninfected infants. Serial samples showed that HCV RNA persisted in 6 infants for at least 18 to 54 months.
Conclusions. Our study is in accordance with other studies that have shown low overall HCV vertical transmission risk and a trend toward higher risk with maternal risk factors such as HIV-coinfection or HCV viremia. A delay in infant HCV antibody response may be associated with HIV coinfection although larger studies are needed to confirm these findings.
Key words: hepatitis C virus, human immunodeficiency virus, vertical transmission, children.
This article has been cited by other articles:
![]() |
S M Davison, G Mieli-Vergani, J Sira, and D A Kelly Perinatal hepatitis C virus infection: diagnosis and management. Arch. Dis. Child., September 1, 2006; 91(9): 781 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Mok, L Pembrey, P-A Tovo, M-L Newell, and for the European Paediatric Hepatitis C Virus Netw When does mother to child transmission of hepatitis C virus occur? Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2005; 90(2): F156 - F160. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schuval, R. B. Van Dyke, J. C. Lindsey, P. Palumbo, L. M. Mofenson, J. M. Oleske, J. Cervia, A. Kovacs, W. N. Dankner, E. Smith, et al. Hepatitis C Prevalence in Children With Perinatal Human Immunodeficiency Virus Infection Enrolled in a Long-term Follow-up Protocol Arch Pediatr Adolesc Med, October 1, 2004; 158(10): 1007 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Laskus, M. Radkowski, J. Jablonska, K. Kibler, J. Wilkinson, D. Adair, and J. Rakela Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages Blood, May 15, 2004; 103(10): 3854 - 3859. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Gismondi, E. I. Turazza, S. Grinstein, M. C. Galoppo, and M. V. Preciado Hepatitis C Virus Infection in Infants and Children from Argentina J. Clin. Microbiol., March 1, 2004; 42(3): 1199 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L Pappalardo Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis Int. J. Epidemiol., October 1, 2003; 32(5): 727 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Salomon, M. C. Weinstein, J. K. Hammitt, and S. J. Goldie Empirically Calibrated Model of Hepatitis C Virus Infection in the United States Am. J. Epidemiol., October 15, 2002; 156(8): 761 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
A H Mohsen, P Easterbrook, C B Taylor, and S Norris Hepatitis C and HIV-1 coinfection Gut, October 1, 2002; 51(4): 601 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Hadzic Hepatitis C in pregnancy Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2001; 84(3): 201F - 204. [Full Text] |
||||
![]() |
M. Bonacini and M. Puoti Hepatitis C in Patients With Human Immunodeficiency Virus Infection: Diagnosis, Natural History, Meta-analysis of Sexual and Vertical Transmission, and Therapeutic Issues Arch Intern Med, December 11, 2000; 160(22): 3365 - 3373. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Gibb, P E Neave, P A Tookey, M Ramsay, H Harris, K Balogun, D Goldberg, G Mieli-Vergani, and D Kelly Active surveillance of hepatitis C infection in the UK and Ireland Arch. Dis. Child., April 1, 2000; 82(4): 286 - 291. [Abstract] [Full Text] |
||||
![]() |
Vertical Transmission of Hepatitis C Virus Is Low Journal Watch Dermatology, October 1, 1998; 1998(1001): 15 - 15. [Full Text] |
||||
![]() |
Vertical Transmission of Hepatitis C Virus Is Low Journal Watch (General), August 18, 1998; 1998(818): 2 - 2. [Full Text] |
||||